Global Urine Monitoring Systems Market Report and Forecast 2024-2032

Global Urine Monitoring Systems Market Outlook

The global urine monitoring systems market size was valued at USD 571.55 million in 2023, driven by the emphasis on continuous urine flow monitoring for kidney failure in critically ill patients globally. The market is expected to grow at a CAGR of 9.2% during the forecast period of 2024-2032, with the values likely to rise from USD 624.14 million in 2024 to USD 1,262.00 million by 2032.

Urine Monitoring Systems: Introduction

Urine monitoring system is a diagnostic method to assess and monitor urine output of an ICU patient. It is used to measure urine flow and volume in patients. If the kidneys are producing an adequate amount of urine, it indicates that they are oxygenated and well perfused, otherwise, the person might be suffering from some pathological issue.

Careful and regular urine monitoring can also lead to early detection of an acute kidney injury (AKI), oliguria (low urine output) along with better fluid management in the body. With effective technical advancements, urine monitoring systems are now both manual and automatic.

Global Urine Monitoring Systems Market Analysis

Acute kidney injury is a common illness among ICU-admitted patients, associated with high morbidity and mortality. It occurs in over 55%  of the ICU patients. In such conditions, optimal fluid management holds high significance for early detection and avoiding complications. Patients with such critical complications need a urine monitoring system on high priority. Therefore, the market size for urine monitoring system has increased over the years.

In any critical care unit, almost all vitals are measured electronically to provide continuous and precise readings. Manual recording can be time-consuming and require visual evaluation along with data recording. Nowadays, healthcare practitioners widely rely on automated devices to get every minute detail so that they can minimise any chance of error. Hence, urine monitoring systems market growth can be anticipated in the forthcoming years with the rising need for automated devices.

Global Urine Monitoring Systems Market Segmentation

Market Breakup by Product Type

• Manual

• Automatic

Market Breakup by Usage

• Disposable

• Reusable

Market Breakup by End User

• Hospitals

• Specialty Clinics

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Urine Monitoring Systems Market Overview

Approximately 5.7 million people  are admitted to ICUs annually in the United States alone. More than 1 in every 7 United States adults, which turns out be around 35.5 million people are estimated to have a chronic kidney disease.  With the rising demand for solutions, there have been several advancements to deal with the ailments. Hence, the North American region has held the largest urine monitoring systems market share.

In the coming years, the market share appears to be making a shift. Asian countries, like Taiwan and Japan,  now have a high prevalence for kidney failures, followed by Mexico. Hence, the need for urine monitoring systems is predicted to increase and deviate from the existing market share.

Urine monitoring systems are also a necessity for people with diabetic nephropathy as well. Diabetic nephropathy is a condition that affects the kidneys’ natural ability to filter out toxins and wastes. Early detection and regular monitoring can lower the risk of complications. Since, the Asian region including China and Pakistan have a high rate of diabetic patients, a surge in the demand for such devices can be anticipated in the territory.

Global Urine Monitoring Systems Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Future Path Medical Holding Company LLC

• Cardinal Health

• Potrero Medical

• Navamedic ASA

• F. Hoffmann-La Roche Ltd.

• RenalSense Ltd.

• Roche Holding AG

• Medispec Ltd

Key Highlights of the Report